{"altmetric_id":2699543,"counts":{"readers":{"mendeley":5,"citeulike":0,"connotea":0},"news":{"unique_users_count":1,"unique_users":["examiner_com"],"posts_count":1},"total":{"posts_count":1}},"citation":{"abstract":"This study evaluated the efficacy and tolerability of desvenlafaxine succinate (desvenlafaxine) in the treatment of major depressive disorder (MDD).","abstract_source":"pubmed","altmetric_jid":"4f6fa6223cf058f610007bee","authors":["Michael R Liebowitz","Paul P Yeung","Richard Entsuah"],"first_seen_on":"2014-09-20T01:26:32+00:00","issns":["1555-2101"],"issue":"11","journal":"Journal of Clinical Psychiatry","last_mentioned_on":1411170618,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18052559"],"pmid":"18052559","pubdate":"2007-11-01T00:00:00+00:00","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"},{"name":"Psychology And Cognitive Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["psychiatry"],"title":"A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder.","type":"article","volume":"68","mendeley_url":"http:\/\/www.mendeley.com\/research\/randomized-doubleblind-placebocontrolled-trial-desvenlafaxine-succinate-adult-outpatients-major-depr"},"altmetric_score":{"score":8,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":8},"context_for_score":{"all":{"total_number_of_other_articles":4614522,"mean":5.4139113567448,"rank":539940,"this_scored_higher_than_pct":88,"this_scored_higher_than":4063304,"rank_type":"exact","sample_size":4614522,"percentile":88},"similar_age_3m":{"total_number_of_other_articles":119341,"mean":8.5378064353946,"rank":18642,"this_scored_higher_than_pct":84,"this_scored_higher_than":100473,"rank_type":"exact","sample_size":119341,"percentile":84},"this_journal":{"total_number_of_other_articles":1828,"mean":4.7162484948002,"rank":280,"this_scored_higher_than_pct":84,"this_scored_higher_than":1536,"rank_type":"exact","sample_size":1828,"percentile":84},"similar_age_this_journal_3m":{"total_number_of_other_articles":60,"mean":3.1501694915254,"rank":9,"this_scored_higher_than_pct":85,"this_scored_higher_than":51,"rank_type":"exact","sample_size":60,"percentile":85}}},"demographics":{"users":{"mendeley":{"by_status":{"Student  > Ph. D. Student":1,"Other":2,"Student  > Master":2},"by_discipline":{"Medicine and Dentistry":2,"Social Sciences":1,"Psychology":2}}},"geo":{"mendeley":{"DK":1}}},"posts":{"news":[{"title":"Studies on desvenlafaxine","url":"http:\/\/www.examiner.com\/article\/studies-on-desvenlafaxine","license":"public","citation_ids":[2699540,2699541,2699542,2699543],"posted_on":"2014-09-19T23:50:18+00:00","summary":"In 2007, a double-blind, placebo-controlled study of the effectiveness and safety of desvenlafaxine in treating major depression was carried out. It was found to be a safe and effective short-term treatment of MDD. In another study conducted...","author":{"name":"Examiner.com","url":"http:\/\/examiner.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/052\/normal\/Screen_Shot_2015-02-16_at_12.06.50.png?1424088431"}}]}}